Trends in pancreatic cancer incidence in nine SEER Cancer Registries, 1973-2002

Annals of Oncology

Volumn 18, Issue 7, 2007, Pages 1268-1279

  Zhang, Jun ^a,b   Dhakal, I ^a   Yan, H ^c   Phillips, M ^a,b   Kesteloot, H ^d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b Arkansas Department Health and Human Services   (United States)

^c XI'AN JIAOTONG UNIVERSITY   (China)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Epidemiology; Incidence; Pancreatic cancer; SEER Cancer Registries; Trends

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; RACE; REGRESSION ANALYSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; UNITED STATES;

EID: 34547840263     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm123     Document Type: Article

References (45)

1. American Cancer Society. Cancer Facts & Figures. Atlanta, GA: American Cancer Society 2005.
2. Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol 2004; 34: 238-244.
3. Potter JD. Pancreas cancer - we know about smoking, but do we know anything else? Am J Epidemiol 2002; 155: 793-795; discussion 796-797.
4. Kern S, Hruban R, Hollingsworth MA et al. A whilte paper: The product of a pancreas cancer think tank. Cancer Res 2001; 61: 4923-4932.
5. Sahmoun AE, D'Agostino RA Jr, Bell RA, Schwenite DC. International variation in pancreatic cancer mortality for the period 1955-1998. Eur J Epidemiol 2003; 18: 801-816.
6. Mulder I, Hoogenveen RT, van Genugten ML et al. Smoking cessation would substantially reduce the future incidence of pancreatic cancer in the European Union. Eur J Gastroenterol Hepatol 2002; 14: 1343-1353.
7. Parkin DM. International variation. Oncogene 2004; 23: 6329-6340.
8. Howe GR, Burch JD. Nutrition and pancreatic cancer, Cancer Causes Control 1996; 7: 69-82.
9. Boffetta P, Castaing M, Brennan P. A geographic correlation study of the incidence of pancreatic and other cancers in Whites. Eur J Epidemiol 2006 21: 39-46.
10. The Surveillance Research Program of the Division of Cancer Control and Population Sciences, National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2004 sub (1973-2002), released April 2005, based on the November 2004 submission. Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch.
11. The Surveillance Research Program of the Division of Cancer Control and Population Sciences, National Cancer Institute. Surveillance Research Program. SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.1.4. Bethesda, MD: National Cancer Institute.
12. Ekbom A, Hunter D. Pancreatic cancer. In Adami HO, Hunter D, Trichopoulos D (eds): Textbook of Cancer Epidemiology. New York, NY: Oxford University Press 2002; 233-247.
13. Joinpoint Regression Program, Version 3.0. Statistical Research and Applications Branch. Betesda, MD: National Cancer Institute 2005.
14. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000; 19: 335-351.
15. Tyczynski JE, Berkel HJ. Mortality from lung cancer and tobacco smoking in Ohio (U.S.): Will increasing smoking prevalence reverse current decreases in mortality? Cancer Epidemiol Biomarkers Prev 2005; 14: 1182-1187.
16. Cayuela A, Rodriguez-Dominguez S, Lopez-Campos JL et al. Joinpoint regression analysis of lung cancer mortality, Andalusia 1975-2000. Ann Oncol 2004; 15: 793-796.
17. Zhang J, Munger RG, West NA et al. Antioxidant intake and risk of osteoporotic hip fracture in Utah: An effect modified by smoking status. Am J Epidemiol 2006; 163: 9-17.
18. Zheng T, Holford TR, Ward BA et al. Time trend in pancreatic cancer incidence in Connecticut 1935-1990, Int J Cancer 1995; 61: 622-627.
19. Wood HE, Gupta S, Kang JY et al. Pancreatic cancer in England and Wales 1975-2000: Patterns and trends in incidence, survival and mortality. Aliment Pharmacol Ther 2006; 23: 1205-1214.
20. Moolgavkar SH, Stevens RG. Smoking and cancers of bladder and pancreas: risks and temporal trends. J Nat Cancer Inst 1981; 67: 15-23.
21. Weiss W, Benarde MA. The temporal relation between cigarette smoking and pancreatic cancer. Am J Public Health 1983: 73: 1403-1404.
22. Levi F, Lucchini F, Negri E, La Vecchia C. Pancreatic cancer mortality in Europe: The leveling of an epidemic. Pancreas 2003; 27: 139-142.
23. Fuchs CS, Colditz GA, Stampfer MJ et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156: 2255-2260.
24. Lin Y, Tamakoshi A, Kawamura T et al. A prospective cohort study of cigarette smoking and pancreatic cancer in Japan. Cancer Causes Control 2002; 13: 249-254.
25. Silverman DT, Dunn A Hoover RN et al. Cigarette smoking and pancreas cancer: A case-control study based on direct interviews. J Nat Cancer Inst 1994; 86: 1510-1516.
26. Harris JE. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst 1983; 71: 473-479.
27. Garfinkel L. Trends in cigarette smoking in the United States. Prev Med 1997; 26: 447-450.
28. Yun YH, Lim MK, Jung KW et al. Relative and absolute risks of cigarette smoking on major histologic types of lung cancer in Korean men. Cancer Epidemiol Biomarkers Prev 2005; 14: 2125-2130.
29. Ji BT, Chow WH, Gridley G et al. Dietary factors and the risk of pancreatic cancer: A case-control study in Shanghai China. Cancer Epidemiol Biomarkers Prev 1995; 4: 885-893.
30. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR et al. Prospective study of diet and pancreatic cancer in male smokers. Am J Epidemiol 2002; 155: 783-792.
31. Lyon JL, Slattery ML, Mahoney AW, Robison LM. Dietary intake as a risk factor for cancer of the exocrine pancreas. Cancer Epidemiol Biomarkers Prev 1993; 2: 513-518.
32. Zhang J, Zhao Z, Berkel HJ. Animal fat consumption and pancreatic cancer incidence: Evidence of interaction with cigarette smoking. Ann Epidemiol 2005; 15: 500-508.
33. Anderson KE, Sinha R, Kulldorff M et al. Meat intake and cooking techniques: Associations with pancreatic cancer. Mutat Res 2002; 506-607: 225-231.
34. Nothlings U, Wilkens LR, Murphy SP et al. Meat and fat intake as risk factors for pancreatic cancer: The multiethnic cohort study. J Natl Cancer Inst 2005 97: 1458-1465.
35. Anderson KE, Kadlubar FF, Kulldoff M et al. Dietary intake of heterocyclic amines and benzo(a)pyrene: Associations with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2005; 14: 2261-2265.
36. Bennington de Gonzalez A, Sweetland S, Spencer E. A meta-analysis of obesity and the risk of pancreatc cancer. Br J Cancer 2003; 89: 519-523.
37. Michaud DS, Giovannucci E, Willett WC et al. Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA 2001; 286: 921-929.
38. Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A et al. Type-II diabetes and pancreatic cancer: A meta-analysis of 36 studies. Br J Cancer 2005; 92: 2076-2083.
39. Fisher WE. Diabetes: Risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg 2001; 25: 503-508.
40. Stolzenberg-Solomon RZ, Graubard BI, Chad S et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 2005; 294: 2872-2878.
41. Jee SH, Ohrr H, Sull JW et al. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.
42. Shopland DR, Hartman AM, Gibson JT et al. Cigarette smoking among U.S. adults by state and region: Estimates from the current population survey. J Natl Cancer Inst 1996; 88: 1748-1758.
43. Jemal A, Ward E, Thun MJ. Contemporary lung cancer trends among U.S. women. Cancer Epidemiol Biomarkers Prev 2005; 14: 582-585.
44. Van Holten V, Percy C. Conversion of Neoplasms by Topography and Morphology from the International Classification of Disease for Oncology (ICD-O) (First Edition and Field Trials) to International Classification of Disease for Oncology, Second Edition (ICD-0-2). Bethesda, MD: National Cancer Institute, National Institutes of Health 1991.
45. Percy C, Frits A, Ries L. Conversion of Neoplasms by Topography and Morphology from the International Classification of Disease for Oncology, Second Edition to International Classificafion of Disease for Oncology, Third Edition. Bethesda, MD: National Cancer Institute, National Institutes of Health 2000.